News Archives - Marinus Pharmaceuticals

Home
About
Pipeline
Ganaxolone
- References
Investors
Contact

Home
About
Pipeline
Ganaxolone
- References
Investors
Contact

Phase III ganaxolone study trips up Marinus; additional trials ongoing

By Marinus Pharmaceuticals|2016-06-16T12:38:48+00:00June 14th, 2016|News|0 Comments

FDA grants orphan drug status to ganaxolone for pediatric female epilepsy

By Marinus Pharmaceuticals|2016-01-14T21:49:44+00:00April 3rd, 2015|News|0 Comments

Health: Purple Day To Raise Epilepsy Awareness

By Marinus Pharmaceuticals|2015-12-21T13:29:13+00:00March 26th, 2015|News|0 Comments

Eyeing $14B epilepsy market, biopharma firm moves to Philly suburb

By Marinus Pharmaceuticals|2015-12-21T13:31:19+00:00February 11th, 2015|News|0 Comments

Marinus braves a cooling biotech IPO market with a $63M pitch

By Marinus Pharmaceuticals|2015-12-21T13:28:22+00:00May 13th, 2014|News|0 Comments

VCs agree to pump $21M more into developer’s nanotech drug

By Marinus Pharmaceuticals|2015-12-21T13:28:35+00:00January 7th, 2013|News|0 Comments

UC-Davis Gets $3M DoD Grant to Study Marinus’ Ganaxolone in Fragile X Syndrome

By Marinus Pharmaceuticals|2015-12-21T13:26:33+00:00April 13th, 2011|News|0 Comments

Dimmer-switch Drugs

By Marinus Pharmaceuticals|2015-12-21T13:29:58+00:00September 1st, 2009|News|0 Comments

Taking the inflammation out of epilepsy

By Marinus Pharmaceuticals|2015-12-21T13:30:34+00:00January 8th, 2009|News|0 Comments

Copyright 2016 Marinus Pharmaceuticals, Inc. | All Rights Reserved | Terms of Use | Privacy Policy